Oramed Pharmaceuticals (ORMP) Shares Issued (2016 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Shares Issued came in at $283008.0 in Q4 2025, down 80.38% YoY from $1.4 million in Q4 2024, and down 80.38% on a QoQ basis from $1.4 million in Q4 2024.
Oramed Pharmaceuticals (ORMP) Shares Issued (2016 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 10 years of Shares Issued data on file, last reported at $283008.0 in Q4 2025.
- Quarterly Shares Issued fell 80.38% year-over-year to $283008.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283008.0 (down 80.38% YoY) and the FY2025 annual result came in at $283008.0, down 80.38% from the prior year.
- Shares Issued declined to $283008.0 in Q4 2025, from $1.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $2.0 million in Q4 2022 to a low of $86500.0 in Q3 2023.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued soared 1128.32% — and 2025, when it sank 80.38%.
- Tracing ORMP's Shares Issued over 5 years: stood at $859447.0 in 2021, then soared by 137.56% to $2.0 million in 2022, then retreated by 6.47% to $1.9 million in 2023, then slipped by 24.48% to $1.4 million in 2024, then slumped by 80.38% to $283008.0 in 2025.
- The last three Shares Issued figures came in at $283008.0 (Q4 2025), $1.4 million (Q4 2024), and $1.1 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,008.00 |
| Dec 31, 2025 | 283,008.00 |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Sep 30, 2023 | 86,500.00 |
| Sep 30, 2023 | 86,500.00 |
| Dec 31, 2022 | 2.04 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Aug 31, 2021 | 859,447.00 |
| Aug 31, 2021 | 859,447.00 |
| Aug 31, 2020 | 103,152.00 |
| Aug 31, 2020 | 103,152.00 |
| Aug 31, 2019 | 47,152.00 |
| Aug 31, 2019 | 47,152.00 |
| Aug 31, 2018 | 55,486.00 |
| Aug 31, 2018 | 55,486.00 |